Hydrogen Therapy Helps Lupus Patient Reduce Heart Problems and Fatigue
Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction
Research hubs: Chronic Fatigue · Cardiovascular System
- Evidence type
- Case report or series · Human study
- Authors
- Yun-Ting Lin, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Hsiao-Chen Liu, Kuang-Yih Wang, Feng-Cheng Liu
- Journal
- In Vivo
- Year
- 2025
- PMID
- 40010949
- Study Type
- Human
- Participants
- 1
- Delivery
- Gas
- Dose
- one H2 capsule daily
- H₂ concentration
- 0.6 mM in 200 ml
- Funding
- National Science and Technology Council, Taiwan (NSTC 112-2314-B-016-033); National Science and Technology Council, Taiwan (NSTC 113-2314-B-016-052); Tri-Service General Hospital, Taiwan (TSGH-E-112218); Tri-Service General Hospital, Taiwan (TSGH-E-113238)
- Conflicts of interest
- None declared
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 4 (OpenAlex, as of November 2026)
- Country
- Taiwan
TL;DR
Molecular hydrogen therapy may help reduce fatigue and improve heart and immune function in patients with lupus, without the side effects of traditional treatments.
Key Finding
A lupus patient with heart failure who received molecular hydrogen therapy showed improvements in cardiac function, reduced autoimmune markers, and significant fatigue reduction while tapering off steroids.
Summary
This report describes a single patient with lupus (an autoimmune disease affecting multiple organs) and heart failure who received molecular hydrogen therapy alongside standard treatments. Over several months, the patient showed improvements in heart function, reduced levels of disease-related antibodies, changes in immune cells, and less fatigue. She was also able to reduce her steroid dose while staying stable.
Practical Takeaway
This is a single case report, which is the lowest level of evidence and cannot establish whether hydrogen therapy actually caused the improvements or whether they would occur in other lupus patients. While the results are interesting, much larger and more rigorous studies would be needed before drawing any conclusions about hydrogen's role in treating lupus or autoimmune disease.
Abstract (excerpt)
Background/aim: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multi-organ inflammation and damage across multiple organs, typically managed with steroids and immunomodulators. However, prolonged use of these treatments is often associated with significant side…